RecruitingNCT07592390

Cannabigerol Oil for Adolescents With ADHD (CAN-ADHD)

A short description of this study’s research objective has not yet been verified.

Medication studyAges 12–17Brazil

The study in practice

Understand this study

This study is for people with ADHD. Listed age limits: 12 years to 17 years. Other eligibility criteria apply.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateEstimated: May 1, 2026

Recruitment status: Recruiting
Enrollment listed in the registry: 60
Sponsor: Universidade do Sul de Santa Catarina
Sponsor type: Unknown or unclear
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 1, Phase 2
Locations: Brazil
Age range: From 12 Years to 17 Years
Official registry ID: NCT07592390
Official title: Potential Effects of Cannabigerol in Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial (CAN-ADHD)

Study ID: NCT07592390. We help you review the study, but cannot decide medical eligibility.

Recruiting

Tubarão

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is Universidade do Sul de Santa Catarina.

Does this study involve medication?

Yes. The study involves medication, including Experimental: Full-spectrum CBG oil 30 mg/mL and Placebo oil (MCT oil).

Who can participate?

This study is for people with ADHD. Listed age limits: 12 years to 17 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.